Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
The Global Reading Room: A Slowly Growing Part-Solid Lung Nodule.
AJR Am J Roentgenol. 2024;223:e2330672.
PubMed
Rapid examination of lung tissues by nonlinear microscopy.
Am J Clin Pathol. 2024;162:369-378.
PubMed
Abstract available
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During
Checkpoint Blockade.
Am J Respir Crit Care Med. 2024;210:919-930.
PubMed
Abstract available
Discovery of Two Novel Immunoepitopes and Development of a Peptide-based
Sarcoidosis Immunoassay.
Am J Respir Crit Care Med. 2024;210:908-918.
PubMed
Abstract available
Real-world Decision-making Process for Stereotactic Body Radiotherapy Versus
Minimally Invasive Surgery in Early-stage Lung Cancer Patients.
Ann Surg. 2024 Oct 1. doi: 10.1097/SLA.0000000000006552.
PubMed
Abstract available
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant
NSCLC.
Anticancer Res. 2024;44:4505-4516.
PubMed
Abstract available
Magnolol Induces Apoptosis and Suppresses Immune Evasion in Non-small Cell Lung
Cancer Xenograft Models.
Anticancer Res. 2024;44:4327-4337.
PubMed
Abstract available
MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP
Expression in Lung Adenocarcinoma.
Anticancer Res. 2024;44:4283-4299.
PubMed
Abstract available
True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant
Pleural Mesothelioma in Japan.
Anticancer Res. 2024;44:4135-4145.
PubMed
Abstract available
Promising Approach for Optimizing In Vivo Fluorescence Imaging in a Tumor Mouse
Model: Precision in Cancer Research.
Anticancer Res. 2024;44:4347-4358.
PubMed
Abstract available
Potential Anti-tumor Properties of PDIA4 in Lung Adenocarcinoma.
Anticancer Res. 2024;44:4309-4315.
PubMed
Abstract available
Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors
in Non-small-cell Lung Cancer With Bone Metastases.
Anticancer Res. 2024;44:4493-4503.
PubMed
Abstract available
Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear
Antibody-positive Patients With Non-small Cell Lung Cancer.
Anticancer Res. 2024;44:4517-4524.
PubMed
Abstract available
Antitumor Potential of Guttiferone E Combined With Carboplatin Against
Osimertinib-resistant H1975 Lung Cancer Through Apoptosis.
Anticancer Res. 2024;44:4175-4188.
PubMed
Abstract available
Sometimes it's What it Doesn't Look Like: Atypical Dissemination of Lung
Adenocarcinoma.
Arch Bronconeumol. 2024;60:664-665.
PubMed
A clinically applicable model more suitable for predicting malignancy or
benignity of pulmonary ground glass nodules in women patients.
BMC Cancer. 2024;24:1225.
PubMed
Abstract available
Bi-weekly irinotecan is an effective and convenient regimen in the treatment of
relapsed or refractory small cell lung cancer.
BMC Cancer. 2024;24:1218.
PubMed
Abstract available
Clinical outcomes and synergistic effect between radiotherapy and immunotherapy
in patients with extensive-stage small cell lung cancer: a real-world study.
BMC Cancer. 2024;24:1206.
PubMed
Abstract available
A simulated trial with reinforcement learning for the efficacy of Irinotecan and
Ifosfamide versus Topotecan in relapsed, extensive stage small cell lung cancer.
BMC Cancer. 2024;24:1207.
PubMed
Abstract available
The American Cancer Society National Lung Cancer Roundtable strategic plan:
Optimizing strategies for lung nodule evaluation and management.
Cancer. 2024 Sep 30. doi: 10.1002/cncr.35181.
PubMed
Abstract available
The American Cancer Society National Lung Cancer Roundtable strategic plan:
Methods for improving turnaround time of comprehensive biomarker testing in
non-small cell lung cancer.
Cancer. 2024 Sep 30. doi: 10.1002/cncr.34926.
PubMed
Abstract available
The American Cancer Society National Lung Cancer Roundtable strategic plan:
Promoting guideline-concordant lung cancer staging.
Cancer. 2024 Sep 30. doi: 10.1002/cncr.34627.
PubMed
Abstract available
The American Cancer Society National Lung Cancer Roundtable strategic plan:
Advancing comprehensive biomarker testing in non-small cell lung cancer.
Cancer. 2024 Sep 30. doi: 10.1002/cncr.34628.
PubMed
Abstract available
A Prime-Boost Vaccination Approach Induces Lung Resident Memory CD8+ T Cells
Derived from Central Memory T Cells That Prevent Tumor Lung Metastasis.
Cancer Res. 2024;84:3173-3188.
PubMed
Abstract available
Pharmacologic Inhibition of EIF4A Blocks NRF2 Synthesis to Prevent Osteosarcoma
Metastasis.
Clin Cancer Res. 2024;30:4464-4481.
PubMed
Abstract available
Safety, Efficacy and Biomarker Analysis of Crizotinib in MET Mutated Non-Small
Cell Lung Cancer - Results from the Drug Rediscovery Protocol.
Clin Cancer Res. 2024 Oct 1. doi: 10.1158/1078-0432.CCR-24-1925.
PubMed
Abstract available
Factors associated with the distribution of brain metastases in lung cancer: a
retrospective study.
Clin Exp Metastasis. 2024 Oct 1. doi: 10.1007/s10585-024-10315.
PubMed
Abstract available
A new proposal of simplified classification of non-small cell lung cancer
oligometastases for easy applicability through systematic literature analysis and
meta-analysis validation.
Eur J Cancer. 2024;212:115043.
PubMed
Abstract available
Nivolumab plus ipilimumab with chemotherapy for non-small cell lung cancer with
untreated brain metastases: A multicenter single-arm phase 2 trial (NIke, LOGiK
2004).
Eur J Cancer. 2024;212:115052.
PubMed
Abstract available
Association between family history with lung cancer incidence and mortality risk
in the Asia Cohort Consortium.
Int J Cancer. 2024 Oct 3. doi: 10.1002/ijc.35191.
PubMed
Abstract available
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for
Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes.
Int J Radiat Oncol Biol Phys. 2024 Aug 8:S0360-3016(24)03173.
PubMed
Abstract available
A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to
immunotherapy for patients with metastatic non-small cell lung cancer.
Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03410.
PubMed
Abstract available
Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for
Patients With Stage I Non-small Cell Lung Cancer in Japan.
Int J Radiat Oncol Biol Phys. 2024 Sep 28:S0360-3016(24)03174.
PubMed
Abstract available
Can We Find a Place for Trophoblast Cell Surface Antigen 2-Targeted Antibody-Drug
Conjugates in Lung Cancer?
J Clin Oncol. 2024 Oct 1:JCO2401900. doi: 10.1200/JCO-24-01900.
PubMed
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of
Individualized Adaptive (chemo)Radiotherapy Using Midtreatment
(18)F-Fluorodeoxyglucose Position Emission Tomography/Computed Tomography in
Stage III Non-Small Cell Lung C
J Clin Oncol. 2024 Oct 4:JCO2400022. doi: 10.1200/JCO.24.00022.
PubMed
Abstract available
Can We Offset Local Recurrence in Locally Advanced Non-Small Cell Lung Cancer?
The Merry-Go-Round of Radiation Dose Escalation and Stubborn Outcomes.
J Clin Oncol. 2024 Oct 4:JCO2401448. doi: 10.1200/JCO-24-01448.
PubMed
Abstract available
Ultrashort Oncologic Whole-Body [(18)F]FDG Patlak Imaging Using LAFOV PET.
J Nucl Med. 2024;65:1652-1657.
PubMed
Abstract available
Risk of Death From Other Diseases in Lung Cancer Patients After Sublobar
Resection Versus Lobectomy.
J Surg Oncol. 2024 Oct 2. doi: 10.1002/jso.27927.
PubMed
Abstract available
Gender, Race, and Ethnicity in Lung Cancer Clinical Trial Participation: Analysis
of 253,845 Patients From 2002 - 2021.
J Thorac Cardiovasc Surg. 2024 Sep 28:S0022-5223(24)00893.
PubMed
Abstract available
Will salvage surgery lead to a paradigm shift in the treatment of stage IV lung
cancer?
J Thorac Cardiovasc Surg. 2024 Oct 4:S0022-5223(24)00808.
PubMed
Accelerated hypofractionated radiotherapy for locally-advanced non-small cell
lung cancer: A systematic review from the International Association for the Study
of Lung Cancer (IASLC) Advanced Radiation Technology (ART) Subcommittee.
J Thorac Oncol. 2024 Sep 28:S1556-0864(24)02353.
PubMed
Abstract available
Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from
the open-label, phase 2 GEOMETRY mono-1 trial.
Lancet Oncol. 2024;25:1357-1370.
PubMed
Abstract available
Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative
non-small cell lung cancer.
Lung Cancer. 2024;197:107970.
PubMed
Abstract available
FZ-AD005, a Novel DLL3-Targeted Antibody-Drug Conjugate with Topoisomerase I
Inhibitor, Shows Potent Antitumor Activity in Preclinical Models.
Mol Cancer Ther. 2024;23:1367-1377.
PubMed
Abstract available
Enhanced capture system for mesenchymal?type circulating tumor cells using a
polymeric microfluidic device 'CTC?Chip' incorporating cell?surface vimentin.
Oncol Rep. 2024;52:156.
PubMed
Abstract available
Recent treatment patterns and real-world survival following first-line anti-PD-L1
treatment for extensive-stage small cell lung cancer.
Oncologist. 2024 Sep 30:oyae234. doi: 10.1093.
PubMed
Abstract available
Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients
who have never smoked: implications for targeted therapies.
Oncologist. 2024;29:e1419-e1424.
PubMed
Abstract available
Differential diagnosis of benign and lung adenocarcinoma presenting as larger
solid nodules and masses based on multiscale CT radiomics.
PLoS One. 2024;19:e0309033.
PubMed
Abstract available
Insulin-like growth factor 1 receptor expression correlates with programmed death
ligand 1 expression and poor survival in non-small cell lung cancer.
PLoS One. 2024;19:e0297397.
PubMed
Abstract available
AeroPath: An airway segmentation benchmark dataset with challenging pathology and
baseline method.
PLoS One. 2024;19:e0311416.
PubMed
Abstract available
Enhancer landscape of lung neuroendocrine tumors reveals regulatory and
developmental signatures with potential theranostic implications.
Proc Natl Acad Sci U S A. 2024;121:e2405001121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.